INVESTOR DEADLINE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January...

Related Keywords

State Of California ,California ,United States ,San Diego ,Turkey ,Turkish ,Enochian Bioscience ,Robbins Geller ,Enochian Biocience ,Gregory Davis ,Michael Albert ,Enochian Biosciences ,Serhat Gumrukcu ,Enron Corp ,Enochian Biosciences Inc ,G Health Research Foundation ,Prnewswire Robbins Geller Rudman Dowd ,Nasdaq ,Robbins Geller Rudman Dowd ,Seraph Research Institute ,Securities Class Action Services Top ,Securities Exchange ,Hindenburg Research ,Us Department Of Justice ,Biosciences Inc ,Securities Exchange Act ,Central District ,G Tech Bio ,Class Period ,Murder For Hire ,Spoon Bending Turkish Magician Built ,Lifetime Of Lies ,Wall Street Journal ,Private Securities Litigation Reform Act ,Class Action Services Top ,Geller Rudman ,Robbins Geller Rudman Amp Dowd Llp ,